Kathrin Meyer

7.2k total citations · 2 hit papers
87 papers, 3.5k citations indexed

About

Kathrin Meyer is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Kathrin Meyer has authored 87 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 35 papers in Genetics and 17 papers in Genetics. Recurrent topics in Kathrin Meyer's work include Neurogenetic and Muscular Disorders Research (33 papers), RNA modifications and cancer (16 papers) and Amyotrophic Lateral Sclerosis Research (14 papers). Kathrin Meyer is often cited by papers focused on Neurogenetic and Muscular Disorders Research (33 papers), RNA modifications and cancer (16 papers) and Amyotrophic Lateral Sclerosis Research (14 papers). Kathrin Meyer collaborates with scholars based in United States, Switzerland and United Kingdom. Kathrin Meyer's co-authors include Brian K. Kaspar, Shibi Likhite, Laura Ferraiuolo, Haiko Sprott, Anne F. Mannion, Arthur H.M. Burghes, Carlos J. Miranda, Lyndsey Braun, Kevin D. Foust and SungWon Song and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Kathrin Meyer

84 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Astrocytes from familial and sporadic ALS patients are toxic to motor neurons

2011 611 citations Carlos J. Miranda, Kathrin Meyer et al. profile →
The C9orf72 protein interacts with Rab1a and the ULK 1 complex to regulate initiation of autophagy

2016 301 citations Christopher P Webster, Emma F. Smith et al. The EMBO Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathrin Meyer United States	26	1.7k	1.3k	1.2k	494	468	87	3.5k
Andrea Malaspina United Kingdom	38	1.6k 0.9×	3.0k 2.4×	1.4k 1.2×	567 1.1×	718 1.5×	104	4.7k
Julaine Florence United States	36	2.9k 1.7×	997 0.8×	1.4k 1.1×	783 1.6×	631 1.3×	66	5.0k
Richard W. Orrell United Kingdom	36	1.7k 1.0×	2.2k 1.7×	1.2k 1.0×	688 1.4×	700 1.5×	90	4.1k
Nicolas Dupré Canada	33	2.0k 1.2×	2.9k 2.3×	1.4k 1.1×	578 1.2×	991 2.1×	148	4.7k
Denise A. Figlewicz United States	33	2.5k 1.4×	2.7k 2.2×	1.7k 1.4×	585 1.2×	1.3k 2.8×	81	5.4k
Thomas Meyer Germany	34	935 0.5×	1.8k 1.5×	1.0k 0.8×	324 0.7×	744 1.6×	106	3.2k
Takao Yasuhara Japan	35	1.4k 0.8×	1.1k 0.9×	981 0.8×	367 0.7×	1.5k 3.2×	172	4.4k
Michael A. van Es Netherlands	30	1.0k 0.6×	2.7k 2.2×	1.5k 1.2×	468 0.9×	443 0.9×	83	3.6k
Ubaldo Del Carro Italy	31	1.5k 0.9×	584 0.5×	613 0.5×	667 1.4×	1.2k 2.6×	81	3.9k
Alcmène Chalazonitis United States	30	1.2k 0.7×	768 0.6×	409 0.3×	558 1.1×	1.1k 2.3×	43	3.1k

Countries citing papers authored by Kathrin Meyer

Since Specialization

Citations

This map shows the geographic impact of Kathrin Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrin Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrin Meyer more than expected).

Fields of papers citing papers by Kathrin Meyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathrin Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrin Meyer. The network helps show where Kathrin Meyer may publish in the future.

Co-authorship network of co-authors of Kathrin Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Kathrin Meyer. A scholar is included among the top collaborators of Kathrin Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathrin Meyer. Kathrin Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khani, Mohammad Reza, et al.. (2025). A 3D non-human primate digital model for pharmacokinetic prediction of intra-cerebrospinal fluid drug neuraxial dispersion. Fluids and Barriers of the CNS. 22(1). 111–111.

Likhite, Shibi, et al.. (2024). The postnatal injection of AAV9-FOXG1 rescues corpus callosum agenesis and other brain deficits in the mouse model of FOXG1 syndrome. Molecular Therapy — Methods & Clinical Development. 32(3). 101275–101275. 4 indexed citations

Rich, Kelly, Xiaojin Zhang, Samantha K. Powers, et al.. (2024). MeCP2 gene therapy ameliorates disease phenotype in mouse model for Pitt Hopkins syndrome. Neurotherapeutics. 21(5). e00376–e00376. 3 indexed citations

Johnson, Tyler B., Shibi Likhite, Katherine A. White, et al.. (2023). Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 disease. Frontiers in Genetics. 14. 9 indexed citations

Ganjibakhsh, Meysam, et al.. (2023). In Vitro Modeling as a Tool for Testing Therapeutics for Spinal Muscular Atrophy and IGHMBP2-Related Disorders. Biology. 12(6). 867–867. 6 indexed citations

Likhite, Shibi, Paula K. Bautista‐Niño, Sergio Alejandro Gómez‐Ochoa, et al.. (2023). Prevalence of Neutralizing Antibodies against Adeno-Associated Virus Serotypes 1, 2, and 9 in Non-Injected Latin American Patients with Heart Failure—ANVIAS Study. International Journal of Molecular Sciences. 24(6). 5579–5579. 6 indexed citations

Liao, Xiao-Hui, Pablo Avalos, Catherine Bresee, et al.. (2022). AAV9-MCT8 Delivery at Juvenile Stage Ameliorates Neurological and Behavioral Deficits in a Mouse Model of MCT8-Deficiency. Thyroid. 32(7). 849–859. 15 indexed citations

Kararoudi, Meisam Naeimi, Shibi Likhite, Kenta Yamamoto, et al.. (2022). Optimization and validation of CAR transduction into human primary NK cells using CRISPR and AAV. Cell Reports Methods. 2(6). 100236–100236. 37 indexed citations

Baggio, Carlo, Anna Kulinich, Sarah Heintzman, et al.. (2022). EphA4 targeting agents protect motor neurons from cell death induced by amyotrophic lateral sclerosis -astrocytes. iScience. 25(9). 104877–104877. 6 indexed citations

10.

Burgdorf, Christof, et al.. (2022). Modern gold standard of cardiac output measurement – A simplified bedside measurement of individual oxygen uptake in the cath lab. Journal of Basic and Clinical Physiology and Pharmacology. 33(5). 639–644. 1 indexed citations

11.

Holmes, Andrew D., Katherine A. White, Tyler B. Johnson, et al.. (2022). Sex-split analysis of pathology and motor-behavioral outcomes in a mouse model of CLN8-Batten disease reveals an increased disease burden and trajectory in female Cln8mnd mice. Orphanet Journal of Rare Diseases. 17(1). 411–411. 4 indexed citations

12.

Baggio, Carlo, et al.. (2021). NMR-Guided Design of Potent and Selective EphA4 Agonistic Ligands. Journal of Medicinal Chemistry. 64(15). 11229–11246. 7 indexed citations

13.

Chugh, Deepti, Chitra C. Iyer, Brian K. Kaspar, et al.. (2021). Voluntary wheel running with and without follistatin overexpression improves NMJ transmission but not motor unit loss in late life of C57BL/6J mice. Neurobiology of Aging. 101. 285–296. 12 indexed citations

14.

Powers, Samantha K., Carlos J. Miranda, Lyndsey Braun, et al.. (2019). Rett syndrome gene therapy improves survival and ameliorates behavioral phenotypes in MeCP2 null (S51.002). Neurology. 92(15_supplement). 5 indexed citations

15.

Iannitti, Tommaso, Shibi Likhite, Ian Coldicott, et al.. (2018). Translating SOD1 Gene Silencing toward the Clinic: A Highly Efficacious, Off-Target-free, and Biomarker-Supported Strategy for fALS. Molecular Therapy — Nucleic Acids. 12. 75–88. 35 indexed citations

16.

Webster, Christopher P, Emma F. Smith, Claudia S. Bauer, et al.. (2016). The C9orf72 protein interacts with Rab1a and the ULK 1 complex to regulate initiation of autophagy. The EMBO Journal. 35(15). 1656–1676. 301 indexed citations breakdown →

17.

Samaranch, Lluı́s, et al.. (2016). Axonal transport of AAV9 in nonhuman primate brain. Gene Therapy. 23(6). 520–526. 41 indexed citations

18.

Huo, Qing, Melis Kayikci, Kathrin Meyer, et al.. (2014). Splicing changes in SMA mouse motoneurons and SMN-depleted neuroblastoma cells: Evidence for involvement of splicing regulatory proteins. RNA Biology. 11(11). 1430–1446. 21 indexed citations

19.

Oesch, Peter, et al.. (2014). Functional Capacity Evaluation: Performance of Patients with Chronic Non-specific Low Back Pain Without Waddell Signs. Journal of Occupational Rehabilitation. 25(2). 257–266. 15 indexed citations

20.

Voigt, Tilman, Kathrin Meyer, Oliver Baum, & Daniel Schümperli. (2010). Ultrastructural changes in diaphragm neuromuscular junctions in a severe mouse model for Spinal Muscular Atrophy and their prevention by bifunctional U7 snRNA correcting SMN2 splicing. Neuromuscular Disorders. 20(11). 744–752. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact